Patrick Griffin

The medical device manufacturer appoints the former Corza Medical CEO to manage its rapid expansion and solidify its leadership in a competitive global market.

Elite firm Davis Polk enters Southern California, poaching a top litigator to spearhead its strategic push into LA's booming entertainment and tech scene.

Amid a history of public scrutiny, Roswell's annual car show aims to mend community ties, one classic car and conversation at a time.

VETS Indexes' 2026 awards reveal a major shift as top firms now see military talent as a key competitive edge, not just a social good.

The top men's natural grooming brand is launching a mineral SPF spray, aiming to solve a problem most men ignore: sun protection. Here’s why it might work.

The new Cal Rehab clinic in Garden Grove marks the 39th joint venture for PRN and MemorialCare, expanding integrated healthcare access in Southern California.

With a history of strong growth, Jefferson Capital's upcoming earnings are a key indicator for investors and the consumer debt market. Will it deliver?

With a new CEO who helped build Liquid Death, A-GAME Beverages is betting his CPG playbook can turn the athlete-backed brand into a national powerhouse.

Despite a 19% revenue jump amidst Greece's record tourism year, hotel group The Azur Selection posts a €5.7M loss, triggering a 'going concern' warning.

Rand Capital's latest dividend highlights its commitment to shareholders. We analyze its portfolio health, BDC strategy, and what this means for investors.

Squads secures $18M to scale its Altitude platform, aiming to replace legacy banking with a stablecoin-powered financial operating system on Solana.

As Amazon's complex fee hikes squeeze seller profits, e-commerce brands are flocking to hybrid fulfillment models for greater cost control and resilience.

U.S. wealth giant Corient enters Canada with C$10B in assets, aiming to disrupt the UHNW landscape with its massive scale and unique fiduciary model.

With its Q1 2026 earnings call set for May 13, FinTech firm Usio faces investor scrutiny after a recent earnings miss. Will it deliver on its growth promises?

With patient enrollment accelerating for its novel lung fibrosis drug, LTI-03, Rein Therapeutics signals progress in a field desperate for new options.

A new partnership will allow consumers to spend stablecoins and Bitcoin at 175M+ locations, blurring the lines between digital wallets and everyday commerce.

Raising $100M led by Sequoia, Parallel Web Systems is building the critical infrastructure for AI agents, reshaping how industries access the internet.

Genomics' big data and Greywolf's novel drugs unite to develop first-in-class treatments for autoimmune diseases, promising a new era of precision medicine.

Billiards is officially back on the program for The World Games 2029 in Karlsruhe, Germany, a landmark achievement for the sport's global growth.

A new AI video solution from V4b.AI promises to solve generative AI's accuracy problem, offering brands a scalable, shoot-free alternative for content.